[Clinical studies on cefsulodin in the pediatric field].
Clinical studies on cefsulodin (CFS) in 6 patients with Pseudomonas aeruginosa infection were carried out and the results as follows. 1. Among 4 patients administered CFS intravenously, 3 patients (urinary tract infection 1, acute purulent otitis media 1, aspiration pneumonia 1) responded well. 2. Two patients with respiratory infection were treated CFS by nebulization. One responded well and another fair. 3. No side effects were observed.
D000281:Administration, Intranasal; D000293:Adolescent; D000367:Age Factors; D002441:Cefsulodin; D002511:Cephalosporins / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D002648:Child; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008297:Male; D011552:Pseudomonas Infections / Q000188:drug therapy*; D013183:Sputum / Q000378:metabolism
D002511:Cephalosporins; D002441:Cefsulodin